Ovation Science has announced it will be participating in the Gravitas Healthcare Investor Day taking place Thursday, October 1st, 2020 virtually.
Ovation Science has announced a corporate update on its revenue generating activities both for its DermSafe® hand sanitizer and its cannabis / CBD products and licenses.
Ovation Science has shipped DermSafe hand sanitizer in bulk supply to its distributor in Guangzhou, China. This shipment will help facilitate their development of a novel mechanism to dispense DermSafe.
Ovation Science has expanded its production of its DermSafe® Hand Sanitizer Lotion by completing the manufacturing of its first order in Canada.
DermSafe® Hand Sanitizing Lotion has received the “Seal of Approval” from the Dermatology Review Panel. The DRP is a panel of Canadian dermatologists that provide an independent review of scientific data for non-prescription products in order to authenticate a product’s claims.
Ovation announces an independent study has successfully proven the effectiveness of its DermSafe® hand sanitizer lotion against a human coronavirus (Beta Coronavirus strain OC43), a surrogate for SARS-CoV-2 (the virus that causes COVID-19).
Ovation Science has expanded distribution of its DermSafe® hand sanitizer lotion to Mexico. Mexico, have made their first purchase of over 10,000 bottles of DermSafe, which they will begin distributing through-out Mexico.
Ovation Science has signed a revised agreement for additional rights for its DermSafe hand sanitizer. It provides Ovation with immediate additional rights which will assist in the sales and marketing of the product internationally.
Ovation is providing an update to its previous disclosures regarding its DermSafe® hand sanitizer product. This release provides updates to regulatory status, sales, manufacturing, and the science which supports DermSafe.
Ovation Science announces a proposed private placement offering of up to 4,000,000 units (each a “Unit”) at a price of $0.42 per Unit for total proceeds of up to $1,680,000 (the “Offering”).
